Table 1 Baseline characteristics of the patients included in the trial (intention to treat)
Characteristic | Appendectomy (N =) | Control (N =) |
|---|---|---|
Age (years) | ||
Age at diagnosis (years) | ||
Gender, female, n (% n/N) | ||
Disease duration (years) | ||
Smoking status, n (% n/N) | ||
Current | ||
Former | ||
BMI (kg/m2) | ||
ASA physical status classification grade > II, n (% n/N) | ||
PSC, n (% n/N) | ||
Family history of IBD, n (% n/N) | ||
Medication at baseline | ||
No medication, n (% n/N) | ||
Topical therapy, n (% n/N) | ||
5-ASA, n (% n/N) | ||
Systemic steroids, n (% n/N) | ||
Immunomodulators, n (% n/N) | ||
Extent of disease | ||
Proctitis, n (% n/N) | ||
Left-sided colitis, n (% n/N) | ||
Pancolitis, n (% n/N) | ||
Start of most recent exacerbation UC before randomisation (weeks) |